DK1458364T3 - Farmaceutiske kompositioner omfattende metformin og glibenclamid til behandling af type-II diabetes mellitus - Google Patents

Farmaceutiske kompositioner omfattende metformin og glibenclamid til behandling af type-II diabetes mellitus

Info

Publication number
DK1458364T3
DK1458364T3 DK02791739T DK02791739T DK1458364T3 DK 1458364 T3 DK1458364 T3 DK 1458364T3 DK 02791739 T DK02791739 T DK 02791739T DK 02791739 T DK02791739 T DK 02791739T DK 1458364 T3 DK1458364 T3 DK 1458364T3
Authority
DK
Denmark
Prior art keywords
glibenclamide
metformin
treatment
type
pharmaceutical compositions
Prior art date
Application number
DK02791739T
Other languages
Danish (da)
English (en)
Inventor
Alessandro Tosetti
Mauro Guiducci
Giovanni Viti
Original Assignee
Menarini Int Operations Lu Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11442301&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1458364(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Menarini Int Operations Lu Sa filed Critical Menarini Int Operations Lu Sa
Application granted granted Critical
Publication of DK1458364T3 publication Critical patent/DK1458364T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02791739T 2001-11-29 2002-11-29 Farmaceutiske kompositioner omfattende metformin og glibenclamid til behandling af type-II diabetes mellitus DK1458364T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001FI000230A ITFI20010230A1 (it) 2001-11-29 2001-11-29 Composizioni farmaceutiche per il trattamento del diabete mellito di tipo ii
PCT/EP2002/013497 WO2003045355A1 (en) 2001-11-29 2002-11-29 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus

Publications (1)

Publication Number Publication Date
DK1458364T3 true DK1458364T3 (da) 2008-06-23

Family

ID=11442301

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02791739T DK1458364T3 (da) 2001-11-29 2002-11-29 Farmaceutiske kompositioner omfattende metformin og glibenclamid til behandling af type-II diabetes mellitus

Country Status (40)

Country Link
US (1) US20050053661A1 (el)
EP (1) EP1458364B1 (el)
JP (1) JP4474162B2 (el)
KR (1) KR20040079898A (el)
CN (1) CN1596103B (el)
AR (1) AR037407A1 (el)
AT (1) ATE387190T1 (el)
AU (1) AU2002358061B2 (el)
BR (1) BR0214403A (el)
CA (1) CA2466677A1 (el)
CO (1) CO5590906A2 (el)
CY (1) CY1107966T1 (el)
DE (1) DE60225331T2 (el)
DK (1) DK1458364T3 (el)
EA (1) EA006766B1 (el)
EG (1) EG24124A (el)
ES (1) ES2302862T3 (el)
HK (1) HK1069974A1 (el)
HN (1) HN2002000341A (el)
HR (1) HRP20040501A2 (el)
HU (1) HUP0402154A3 (el)
IL (1) IL162143A0 (el)
IT (1) ITFI20010230A1 (el)
MA (1) MA27087A1 (el)
MX (1) MXPA04004974A (el)
MY (1) MY141243A (el)
NO (1) NO20042713L (el)
NZ (1) NZ533779A (el)
PA (1) PA8559801A1 (el)
PE (1) PE20030580A1 (el)
PL (1) PL206016B1 (el)
PT (1) PT1458364E (el)
RS (1) RS50937B (el)
SI (1) SI1458364T1 (el)
SV (1) SV2004001415A (el)
TN (1) TNSN04095A1 (el)
UA (1) UA81615C2 (el)
UY (1) UY27549A1 (el)
WO (1) WO2003045355A1 (el)
ZA (1) ZA200404880B (el)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055009A1 (en) * 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
PT2316456T (pt) 2003-04-29 2017-09-05 Orexigen Therapeutics Inc Composições para afetar a perda de peso compreendendo naltrexona e bupropion
PE20061245A1 (es) * 2005-03-30 2007-01-06 Generex Pharm Inc Composiciones para la transmision transmucosa oral de la metformina
TWI471145B (zh) * 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
ATE460925T1 (de) * 2006-11-09 2010-04-15 Orexigen Therapeutics Inc Mehrschichtige pharmazeutische formulierungen mit einer schnell auflösenden zwischenschicht
ITMI20062254A1 (it) * 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
CA2725930A1 (en) 2008-05-30 2009-12-30 Orexigen Therapeutics, Inc. Methods for treating visceral fat conditions
CA2638240C (en) 2008-08-29 2010-02-02 Alexander Macgregor Method of treating dysglycemia and glucose excursions
KR101841442B1 (ko) 2010-01-11 2018-03-23 오렉시젠 세러퓨틱스 인크. 주우울증 환자들에 있어서 체중 감량 치료를 제공하는 방법
RU2483717C2 (ru) * 2010-11-22 2013-06-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения диабета (варианты)
US11759441B2 (en) 2011-01-07 2023-09-19 Anji Pharmaceuticals Inc. Biguanide compositions and methods of treating metabolic disorders
US8796338B2 (en) 2011-01-07 2014-08-05 Elcelyx Therapeutics, Inc Biguanide compositions and methods of treating metabolic disorders
US9572784B2 (en) 2011-01-07 2017-02-21 Elcelyx Therapeutics, Inc. Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
US11974971B2 (en) 2011-01-07 2024-05-07 Anji Pharmaceuticals Inc. Compositions and methods for treating metabolic disorders
US9480663B2 (en) 2011-01-07 2016-11-01 Elcelyx Therapeutics, Inc. Biguanide compositions and methods of treating metabolic disorders
MX2013007884A (es) 2011-01-07 2013-09-13 Elcelyx Therapeutics Inc Terapias a base de ligando del receptor quimiosensorial.
US9211263B2 (en) 2012-01-06 2015-12-15 Elcelyx Therapeutics, Inc. Compositions and methods of treating metabolic disorders
KR102231554B1 (ko) 2012-01-06 2021-03-23 앤지 파마 유에스 엘엘씨 대사 장애를 치료하는 조성물 및 방법
KR20200137035A (ko) 2012-01-06 2020-12-08 앤지 파마 유에스 엘엘씨 바이구아나이드 조성물 및 대사 장애를 치료하는 방법
EP2858640B1 (en) 2012-06-06 2020-03-25 Nalpropion Pharmaceuticals LLC Composition for use in a method of treating overweight and obesity in patients with high cardiovascular risk
BR112017009521A2 (pt) 2014-11-11 2017-12-19 Shionogi & Co comprimido de múltiplas camadas que contém um fármaco instável à luz
KR101750690B1 (ko) * 2015-10-28 2017-06-27 주식회사 종근당 메트포르민 및 로베글리타존을 포함하는 약제학적 조성물
CN105596339A (zh) * 2015-12-23 2016-05-25 青岛海之源智能技术有限公司 一种二甲双胍阿昔莫司复方组合物及制备方法
CN110128305A (zh) * 2019-05-10 2019-08-16 天津大学 二甲双胍-甲苯磺丁脲新盐型、其制备方法及医药用途
JP2021120357A (ja) * 2020-01-30 2021-08-19 サンノーバ株式会社 錠剤
GB2599950A (en) * 2020-10-16 2022-04-20 Zentiva Ks Pharmaceutical compositions with low amounts of nitrosamine impurities and methods for producing the same
CN113143940A (zh) * 2020-12-30 2021-07-23 成都恒瑞制药有限公司 一种抗糖尿病药物组合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2347531A1 (de) * 1973-09-21 1975-04-30 Hoechst Ag Arzneizubereitungen zur oralen diabetes-behandlung
IT1276130B1 (it) * 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
CN1203846C (zh) * 1998-03-19 2005-06-01 布里斯托尔-迈尔斯斯奎布公司 高溶解性药物的双相控释递送系统和方法
EP0974356B1 (en) * 1998-07-15 2003-09-24 Merck Sante Tablets comprising a combination of metformin and glibenclamide
US6780432B1 (en) * 2000-05-01 2004-08-24 Aeropharm Technology, Inc. Core formulation
WO2002055009A1 (en) * 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system

Also Published As

Publication number Publication date
ES2302862T3 (es) 2008-08-01
AU2002358061B2 (en) 2007-01-11
CN1596103B (zh) 2010-06-16
EP1458364A1 (en) 2004-09-22
PE20030580A1 (es) 2003-09-05
ITFI20010230A1 (it) 2003-05-29
US20050053661A1 (en) 2005-03-10
EP1458364B1 (en) 2008-02-27
JP2005518360A (ja) 2005-06-23
EA006766B1 (ru) 2006-04-28
EG24124A (en) 2008-07-07
RS50937B (sr) 2010-08-31
HK1069974A1 (en) 2005-06-10
NZ533779A (en) 2007-02-23
HUP0402154A3 (en) 2008-04-28
PL369851A1 (en) 2005-05-02
WO2003045355A1 (en) 2003-06-05
DE60225331D1 (de) 2008-04-10
PA8559801A1 (es) 2003-06-30
ATE387190T1 (de) 2008-03-15
AU2002358061A1 (en) 2003-06-10
EA200400664A1 (ru) 2004-10-28
CA2466677A1 (en) 2003-06-05
MA27087A1 (fr) 2004-12-20
MY141243A (en) 2010-03-31
JP4474162B2 (ja) 2010-06-02
PT1458364E (pt) 2008-05-26
SI1458364T1 (sl) 2008-08-31
SV2004001415A (es) 2004-05-07
CO5590906A2 (es) 2005-12-30
ZA200404880B (en) 2005-07-29
CN1596103A (zh) 2005-03-16
DE60225331T2 (de) 2009-02-26
HUP0402154A2 (hu) 2005-02-28
CY1107966T1 (el) 2013-09-04
RS47304A (en) 2006-10-27
IL162143A0 (en) 2005-11-20
MXPA04004974A (es) 2004-08-11
UY27549A1 (es) 2003-06-30
BR0214403A (pt) 2004-10-19
NO20042713L (no) 2004-07-16
UA81615C2 (ru) 2008-01-25
TNSN04095A1 (en) 2006-06-01
PL206016B1 (pl) 2010-06-30
HRP20040501A2 (en) 2004-12-31
HN2002000341A (es) 2009-12-07
AR037407A1 (es) 2004-11-10
KR20040079898A (ko) 2004-09-16

Similar Documents

Publication Publication Date Title
DK1458364T3 (da) Farmaceutiske kompositioner omfattende metformin og glibenclamid til behandling af type-II diabetes mellitus
CL2004001069A1 (es) Compuestos derivados de 1-benzoil-isoquinolinas sustituidos; procedimiento de preparacion, composicion farmaceutica; y uso para el tratamiento o profilaxis de diabetes tipo ii.
NO20035298D0 (no) CDK-inhiberende pyrimider, deres fremstilling og deres anvendelse som legemidler
DK1309324T3 (da) Antikonvulsive derivater egnede til behandling og forebyggelse af udvikling af type II diabetes mellitus og syndrom X
NO20033566L (no) Acylerte 6,7,8,9-tetrehydro-5H-benzocykloheptenyl-aminer og deres anvendelse som farmasöytiske midler
DK1183020T3 (da) (3-trihalogenmethylphenoxy)(4-halogenphenyl) til behandling af insulinresistens og type 2-diabetes
ATE204754T1 (de) Pharmazeutische zusammensetzung von metformin und fibrat, und ihre verwendung zur behandlung von hyperglykämie
DK1380209T3 (da) Sammensætning til et middel til bekæmpelse af skadelige organismer og fremgangsmåde til anvendelse af samme
NO20033726L (no) Xantin-derivater, fremstilling og anvendelse derav som et medikament
HUP0401665A3 (en) Alfa and beta-form crystal of an aminothiazolyl acetanilide derivative, their use and pharmaceutical compositions containing them
ATE303802T1 (de) 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phen l enthaltendes arzneimittel mit verzögerter wirkstofffreisetzung
DK1484970T3 (da) Benzamider og sammensætninger omfattende benzamider til anvendelse som fungicider
NO20033100D0 (no) Uorganiske matrikssammensetninger og kompositter som inneholder matrikssammensetningen
NO20054876D0 (no) Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser
NO20042635L (no) 5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin
DE60204349D1 (de) 4-(1,3,4-thiadiazolyl-2-yl)-1,4-diazabizyklo- 3.2.2 nonanderivate, ihre herstellung und ihre therapeutische verwendung
DK1322158T3 (da) Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf
IS6378A (is) Efnasambönd og samsetningar gegn dvergveirum, notkun þeirra til lyfjagerðar og efni til að framleiða þau
DK1411917T3 (da) Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser
NO20040860L (no) Farmasoytisk sammensetning som innbefatter lumiracoxib
DK1412343T3 (da) Forbindelser, som er stærke inhibitorer af Na+/Ca2+udbytningsmekanismen og er nyttige til behandling af arytmier
DK1170281T3 (da) 1,1- og 1,2-disubstituerede cyclopropaner, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK1663191T3 (da) Sammensætning omfattende rosiglitazon og metformin
DK1173436T3 (da) Thiazolidindionderivat og anvendelse deraf som antidiabetikum
DK1404663T3 (da) Eurotinoner og derivater deraf, fremgangsmåde til deres fremstilling og anvendelse heraf